{"id":"NCT01152554","sponsor":"AstraZeneca","briefTitle":"A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder","officialTitle":"A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III, Long-Term Safety and Tolerability Study of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06","primaryCompletion":"2012-02","completion":"2012-02","firstPosted":"2010-06-29","resultsPosted":"2012-10-29","lastUpdate":"2014-04-11"},"enrollment":813,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder","MDD","Depression"],"interventions":[{"type":"DRUG","name":"TC-5214","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"SSRI/Serotonin/SNRI + TC-5214 1-4 mg","type":"EXPERIMENTAL"},{"label":"SSRI/Serotonin/SNRI + placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if TC-5214 or placebo (a tablet that looks like medicine tablet or capsule, but contains no active medicine) is safe and effective when taken for 52 weeks with another antidepressant medicine.","primaryOutcome":{"measure":"Frequency of Patients Experiencing at Least One Adverse Event (AE)","timeFrame":"Randomization (Week 0) to end of the follow-up period (Week 54)","effectByArm":[{"arm":"TC-5214","deltaMin":82.4,"sd":null},{"arm":"Placebo","deltaMin":84.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":94,"countries":["United States","Puerto Rico"]},"refs":{"pmids":["25514064"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=337&filename=CSR-D4130C00007.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=337&filename=D4130C00007_Revised_CSP_1_redacted.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":201},"commonTop":["Headache","Upper Respiratory Tract Infection","Constipation","Dizziness","Nausea"]}}